More
    Guided Solutions - Connecting Talent With Innovation/div>

    InBrain Neuroelectronics raises $50M Series B to support BCI

    InBrain Neuroelectronics closed a Series B financing round with proceeds totalling $50 million. The Barcelona, Spain-based company also secured additional funding and support from Merck...

    InterVene Attracts $13 Million in Series A Financing for Recana catheter system

    InterVene closed a $13 million Series A financing round co-led by new investor Treo Ventures and existing supporter RiverVest Venture Partners. In conjunction with...

    Heart medical device company Innoventric raises $28.5m

    Israeli heart medical device company Innoventric completed a $28.5 million Series B financing round. The company has developed a device for the treatment of...

    Onward raises $54m to continue neuromodulation trials

    Onward Medical has raised $54m (€50m) via a bookbuild offering, with proceeds going towards ongoing clinical studies and an expected commercial launch of one...

    Sonavex raises $15M to support novel ultrasound solutions

    Sonavex closed a $15 million Series A-2 financing round to support its ultrasound technologies. The Baltimore, Maryland-based Johns Hopkins spinout develops the EchoMark and EchoSure...

    Okami Medical closes $32.5M financing to support catheter tech for peripheral vascular occlusion

    Okami Medical announced it closed a $32.5 million financing round to support its catheter-based technologies. Aliso Viejo, California-based Okami develops multiple technologies for peripheral vascular...

    Diagnostics company Cirdan secured a £7.5m investment

    Lisburn-based medical imaging company Cirdan has raised £7.5 million (€8.9 million) from a pair of investors in a funding round it says will help...

    Horizon Surgical Systems raises $30 million in Series A financing

    Horizon Surgical Systems, Inc., a privately-held, micro-robotics company advancing microsurgery with automated AI-enabled robotics, announced the close of a $30M Series A financing. The...

    Rivermark Medical closes $30 million Series C financing to advance FloStent™ system for benign prostatic hyperplasia

    Rivermark Medical, a leader in minimally invasive solutions for Benign Prostatic Hyperplasia (BPH), closed a $30 million Series C financing round. The round was...

    Latest articles